Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

TCP1 alpha/CCTA antibody (AA 3-106) (Biotin)

The Mouse Monoclonal anti-TCP1 alpha/CCTA antibody has been validated for WB, IF and FACS. It is suitable to detect TCP1 alpha/CCTA in samples from Human.
Catalog No. ABIN6189945

Quick Overview for TCP1 alpha/CCTA antibody (AA 3-106) (Biotin) (ABIN6189945)

Target

See all TCP1 alpha/CCTA (TCP1) Antibodies
TCP1 alpha/CCTA (TCP1) (T-Complex 1 (TCP1))

Reactivity

  • 216
  • 138
  • 86
  • 21
  • 21
  • 20
  • 19
  • 17
  • 17
  • 15
  • 13
  • 11
  • 10
  • 4
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
Human

Host

  • 170
  • 48
  • 26
  • 1
  • 1
Mouse

Clonality

  • 149
  • 97
Monoclonal

Conjugate

  • 79
  • 17
  • 12
  • 10
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
This TCP1 alpha/CCTA antibody is conjugated to Biotin

Application

  • 130
  • 72
  • 54
  • 53
  • 52
  • 46
  • 44
  • 44
  • 41
  • 24
  • 22
  • 12
  • 11
  • 2
  • 1
Western Blotting (WB), Immunofluorescence (IF), Flow Cytometry (FACS)

Clone

TP63-1786
  • Binding Specificity

    • 39
    • 18
    • 18
    • 15
    • 15
    • 15
    • 15
    • 9
    • 5
    • 4
    • 4
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 3-106

    Purpose

    Mouse Monoclonal anti-p63 (TP63/1786), Biotin Conjugate

    Characteristics

    p63 is a homolog of the tumor suppressor p53. It is identified in basal cells in the epithelial layers of a variety of tissues, including epidermis, cervix, urothelium, breast and prostate. p63 was detected in nuclei of the basal epithelium in normal prostate glands, however, it was not expressed in malignant tumors of the prostate. As a result, p63 has been reported as a useful marker for differentiating benign from malignant lesions in the prostate, particularly when used in combination with markers of high molecular weight cytokeratins and the prostate-specific marker AMACR (P504S). p63 has also been shown to be a sensitive marker for lung squamous cell carcinomas (SqCC), with a sensitivity of ~90 % . Specificity for lung SqCC, vs. lung adenocarcinoma (LADC), is approximately 80 %. In breast tissue, p63 has been identified in myoepithelial cells of normal ducts. Primary antibodies are available purified, or with a selection of fluorescent CF® dyes and other labels. CF® dyes offer exceptional brightness and photostability. Note: Conjugates of blue fluorescent dyes like CF®405S and CF®405M are not recommended for detecting low abundance targets, because blue dyes have lower fluorescence and can give higher non-specific background than other dye colors.

    Immunogen

    Recombinant human p63 protein fragment (aa3-106) (exact sequence is proprietary)

    Isotype

    IgG2b kappa
  • Application Notes

    Flow Cytometry 0.5-1 μg/million cells/0.1 mL
    • Immunofluorescence 1-2 μg/mL
    • Western blotting 0.5-1 μg/mL
    • Optimal dilution for a specific application should be determined by user

    Comment

    HEK293 cells or Prostate Carcinoma or Lung or bladder squamous cell carcinoma

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    100 μg/mL

    Buffer

    PBS/0.1 % BSA/0.05 % azide

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
  • Target

    TCP1 alpha/CCTA (TCP1) (T-Complex 1 (TCP1))

    Alternative Name

    p63

    Molecular Weight

    63 kDa

    Gene ID

    8626, 137569

    UniProt

    Q9H3D4
You are here:
Chat with us!